Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-009600
Filing Date
2020-02-14
Accepted
2020-02-14 16:07:30
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4074
  Complete submission text file 0001209191-20-009600.txt   5512
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNIQUIRE N.V. 113 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Springhorn Jeremy P. (Reporting) CIK: 0001717852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 20619584